Investing.com – J&J reported on Tuesday first quarter that beat analysts’ forecasts and income that fell in need of expectations.

J&J introduced earnings per share of $2.67 on income of $23.43B. Analysts polled by Investing.com anticipated EPS of $2.59 on income of $23.69B.

J&J shares are up 3% from the start of the 12 months, nonetheless down 3.55% from its 52 week excessive of $184.20 set on April 11. They’re outperforming the S&P 500 which is down 7.86% from the beginning of the 12 months.

J&J follows different main Healthcare sector earnings this month

J&J’s report follows an earnings beat by UnitedHealth on Thursday, who reported EPS of $5.49 on income of $80.15B, in comparison with forecasts EPS of $5.38 on income of $78,786M.

BioNTech had beat expectations on March 30 with first quarter EPS of $12.18 on income of $5.53B, in comparison with forecast for EPS of $7.44 on income of $3.92B.

Keep up-to-date on the entire upcoming earnings reviews by visiting Investing.com’s earnings calendar